-
Cross-Reactivity Between SARS-CoV-2 S1-RBD and ACE2 Was Found in the Sera of COVID-19 Patients
A study carried out by Leadgene Biomedical first identified the antibodies against ACE2 in COVID-19 patients, and then found a positive correlation between the amounts of antibodies against ACE2 and S1-RBD.
-
The Right Tool for the Right Job!
Let Leadgene Biomedical’s COVID-19 series products become your comprehensive solutions!
-
Hydrogel Technology Improves the Treatment of CAR-T Cell Therapy on Solid Tumors!
The scientists reported a new approach that utilizes injectable hydrogels to deliver CAR-T cells together with cytokines.
-
Protein Conjugation Kits
Leadgene provides two selection of Conjugation kits for customers, which were special for conjugate tag to antibody or protein. In addition, Conjugation kits has been promoted the development of experiment, such as Flow, Western blot, ELISA, IHC and other research.
-
Tracing Back the Mysterious Ancestry of SARS-CoV-2 Omicron Variant
Two theoretical models speculating the advent of Omicron recapped the need for systematic approaches to pursue better antiviral medication to prevent or treat persistent infections in people with impaired immune systems and to monitor communications of pathogenic microbes in some wildlife that share their surroundings with us.
-
The First FDA Approval TCR Drug for Eye Cancer
The Food and Drug Administration approved the first drug used as treatment for uveal melanoma (UM), an aggressive skin cancer that occurs in the eye tissue.
-
IVT- A Key to Game-Changing Innovations
In vitro transcription helps scientists to develop diagnostic methods and study molecular biology. The applications of IVT are versatile, including synthesis of mRNAs for protein expression, the development of RNA vaccines, the generation of aptamers, gene editing, RNAi, and synthesis of viral RNA for infection experiments.
-
The Revolutionary Era in Vaccinology – mRNA Vaccine
mRNA vaccine consists of lipid nanoparticles (LNPs) wrapped with messenger RNA (mRNA) encoded viral antigens. When we inoculate the mRNA vaccine, the mRNA will translate into viral proteins, and these viral antigens will further induce the immune response in our bodies.
-
Incoming War! How Do SARS-CoV-2 Viruses Arm and Attack Human Bodies?
Recent studies showed that ORF8 may bind to MHC-Ι molecules and mediate their down-regulation. In ORF8-expressing cells, MHC-Ι molecules are selectively targeted and enriched in lysosomes for degradation.
-
GMP-Grade Protein Development
Leadgene's GMP-grade proteins are manufactured in our ISO13485 certified plant. The high-quality GMP-grade proteins support the fast-growing cell therapy manufacturing market.
